Immunotherapy (journal)
Immunotherapy is a peer reviewed medical journal covering immunology and more specifically immunotherapy. It was established in 2009 and is published by Future Medicine. The founding editor-in-chief was Duc Hong Le. The current editors-in-chief are Y. Kawakami, F.M. Marincola, K. Tsang and D.C. Wraith.
 | |
| Discipline | Immunology |
|---|---|
| Language | English |
| Edited by | Y. Kawakami, F.M. Marincola, K. Tsang, D.C. Wraith |
| Publication details | |
| History | 2009-present |
| Publisher | |
| Frequency | 16/year |
| Hybrid | |
| 2.716 (2016) | |
| Standard abbreviations | |
| ISO 4 | Immunotherapy |
| Indexing | |
| CODEN | IMMUCO |
| ISSN | 1750-743X (print) 1750-7448 (web) |
| LCCN | 2009243240 |
| OCLC no. | 495368971 |
| Links | |
Abstracting and indexing
The journal is abstracted and indexed in:
- Biological Abstracts[1]
- BIOSIS Previews[2]
- Chemical Abstracts[3]
- Embase[4]
- Index Medicus/PubMed/MEDLINE[5]
- Science Citation Index Expanded[2]
- Scopus[6]
According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.716, ranking it 90th out of 150 journals in the category "Immunology".[7]
gollark: !hwdyk msg
gollark: !hwdyk msg
gollark: umnikos
gollark: !hwdyk msg
gollark: Pyrotelekinetic
References
- "Biological Abstracts - Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2015-05-12.
- "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2014-12-13.
- "CAS Source Index". Chemical Abstracts Service. American Chemical Society. Retrieved 2014-12-13.
- "Journal titles covered in Embase". Embase. Elsevier. Retrieved 2015-05-12.
- "Immunotherapy". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-12-13.
- "Content overview". Scopus. Elsevier. Retrieved 2015-05-12.
- "Journals Ranked by Impact: Immunology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.